RxDoctor Payments Data

Joshua Han

Family · Glen Burnie, MDNPI 1154514859

Payments from drug & device makers

$6,491in general payments, 2019–2025

Across 430 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Collegium Pharmaceutical, Inc.$1K
  • Indivior Inc.$489
  • Boston Scientific$409
  • AbbVie$348
  • Merck$219
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$6,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,491 in reported general payments places this provider in the 95th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$453,444
Medicare patients
463
Services billed
4,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide23$53,697
PercocetOxycodone Hcl/Acetaminophen11$48,059
Oxycodone Hcl1,984$42,531
Xtampza ErOxycodone Myristate82$39,068
OxycontinOxycodone Hcl88$31,581
Lidocaine151$31,306
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen923$28,336
ZtlidoLidocaine21$19,358
MovantikNaloxegol Oxalate36$14,418
Morphine Sulfate ErMorphine Sulfate613$11,738
Diclofenac Sodium133$8,449
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen348$8,337
Gabapentin596$7,553
BelbucaBuprenorphine Hcl13$6,333
Fentanyl69$5,257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,514$53,69723 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$1,105$45,40195 claims
Scilex Pharmaceuticals Inc.Ztlido$212$19,35821 claims
Redhill Biopharma Inc.Movantik$53$14,41836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,843 family providers in Maryland.

Other family in Glen Burnie

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →